Valdecoxib
- Generic Name
- Valdecoxib
- Brand Names
- Bextra
- Drug Type
- Small Molecule
- Chemical Formula
- C16H14N2O3S
- CAS Number
- 181695-72-7
- Unique Ingredient Identifier
- 2919279Q3W
Overview
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke.
Background
Valdecoxib was removed from the Canadian, U.S., and E.U. markets in 2005 due to concerns about a possible increased risk of heart attack and stroke.
Indication
For the treatment of osteoarthritis and dysmenorrhoea
Associated Conditions
- Osteoarthritis (OA)
- Primary Dysmenorrhoea
- Rheumatoid Arthritis
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath